The combinational effect of vincristine and berberine on growth inhibition and apoptosis induction in hepatoma cells

Journal of Cellular Biochemistry

Volumn 115, Issue 4, 2014, Pages 721-730

  Wang, Ling ^a   Wei, Dandan ^a   Han, Xiaojuan ^a   Zhang, Wei ^a   Fan, Chengzhong ^a   Zhang, Jie ^a   Mo, Chunfen ^a   Yang, Ming ^a   Li, Junhong ^a   Wang, Zhe ^a   Zhou, Qin ^a   Xiao, Hengyi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

APOPTOSIS; BERBERINE; HEPATIC CARCINOMA CELLS; MITOCHONDRIA; VINCRISTINE

Indexed keywords

BERBERINE; MULTIDRUG RESISTANCE PROTEIN 1; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL DEATH; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MTT ASSAY; PRIORITY JOURNAL;

APOPTOSIS; BERBERINE; HEPATIC CARCINOMA CELLS; MITOCHONDRIA; VINCRISTINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BERBERINE; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; VINCRISTINE;

EID: 84892904742     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24715     Document Type: Article

References (62)

1. Allerton R,. 1996. Acute mesenteric ischaemia associated with 5-FU, cisplatin and vincristine chemotherapy. Clin Oncol 8: 116-117.
2. Amin A, Subbaiah T, Abbasi K,. 1969. Berberine sulfate: Antimicrobial activity, bioassay, and mode of action. Can J Microbiol 15: 1067-1076.
3. Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR,. 1988. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109: 267.
4. Chinese Herbals Editor Board tSABoCMoC. 1999. Chinese Herbals (Zhong Hua Ben Cao)editor editors. Shanghai: Shanghai Science and Technology Press. p 11.
5. Choi MS, Yuk DY, Oh JH, Jung HY, Han SB, Moon DC, Hong JT,. 2008. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. Anticancer Res 28: 3777-3784.
6. Dhingra D, Sethi GR, Mantan M,. 2013. Unilateral phrenic nerve palsy: A rare manifestation of vincristine neurotoxicity. Indian J Pediatr [Epub ahead of print].
7. El-Serag HB,. 2002a. Hepatocellular carcinoma: An epidemiologic view. J Clin Gastroenterol 35: S72.
8. El-Serag HB,. 2002b. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36: s74-s83.
9. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M,. 1982. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50: 821-826.
10. Galle K, Blodt S, Wagner H,. 1994. TLC and HPLC detection of alkaloids in Mahonia aquifolium and related plants. Dtsch Apoth Ztg 134: 35.
11. Gasparotto V, Castagliuolo I, Chiarelotto G, Pezzi V, Montanaro D, Brun P, Palù G, Viola G, Ferlin MG,. 2006. Synthesis and biological activity of 7-phenyl-6, 9-dihydro-3 H-pyrrolo [3,2-f] quinolin-9-ones: A new class of antimitotic agents devoid of aromatase activity. J Med Chem 49: 1910-1915.
12. Ghosh AK, Bhattacharyya FK, Ghosh DK,. 1985. Leishmania donovani: Amastigote inhibition and mode of actior of berberine. Exp Parasitol 60: 404-413.
13. Gillies J, Hung K, Fitzsimons E, Soutar R,. 1998. Severe vincristine toxicity in combination with itraconazole. Clin Lab Haematol 20: 123-124.
14. Grycová L, Dostal J, Marek R,. 2007. Quaternary protoberberine alkaloids. Phytochemistry 68: 150-175.
15. Himes RH, Kersey RN, Heller-Bettinger I, Samson FE,. 1976. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res 36: 3798.
16. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH,. 2007. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 81: 719-7728.
17. Huang W,. 1992. A study of the antiarrhythmic mechanism of berberine on delayed activation potassium current by voltage clamp. Zhonghua Xin Xue Guan Bing Za Zhi 20: 310.
18. Jackson DV, Bender RA,. 1979. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. Cancer Res 39: 4346.
19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. 2011. Global cancer statistics. CA Cancer J Clin 61: 69-90.
20. Ji X, Li Y, Liu H, Yan Y, Li J,. 2000. Determination of the alkaloid content in different parts of some Mahonia plants by HPCE. Pharm Acta Helv 74: 387-391.
21. Jongsma A, Riethorst A, Lankelma J, Dekker H, Westerhoff H,. 2000. Evaluating limited specificity of drug pumps. Eur J Biochem 267: 5369-5377.
22. Jordan M,. 2002. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anticancer Agents 2: 1-17.
23. Kim SN, Kim NH, Park YS, Kim H, Lee S, Wang Q, Kim YK,. 2009. 7-Diethylamino-3 (2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells. Biochem Pharmacol 77: 1773-1779.
24. Kim H, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS,. 2013. Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients. Childs Nerv Syst 29: 1851-1858.
25. Koutinos G, Stathopoulos GP, Dontas I, Perrea-Kotsarelis D, Couris E, Karayannacos PE, Deliconstantinos G,. 2002. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: An experimental study. Anticancer Res 22: 815-820.
26. Kuo CL, Chou CC, Yung BYM,. 1995. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 93: 193-200.
27. Lin JP, Yang JS, Chang NW, Chiu TH, Su CC, Lu KW, Ho YT, Yeh CC, Mei-Dueyang, Lin HJ, Chung HG,. 2007. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 27: 3379.
28. Li N, He Y, Wang L, Mo C, Zhang J, Zhang W, Li J, Liao Z, Tang X, Xiao H,. 2011. D-galactose induces necroptotic cell death in neuroblastoma cell lines. J Cell Biochem 112 (12): 3834-3844.
29. Liu WT, Huang CY, Lu IC, Gean PW,. 2013. Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neuro Oncol 15: 1127-1141.
30. Löw-Friedrich I, Von Bredow F, Schoeppe W,. 1990. In vitro studies on the cardiotoxicity of chemotherapeutics. Chemotherapy 36: 416-421.
31. Mantena SK, Sharma SD, Katiyar SK,. 2006. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 27: 2018.
32. Marinina J, Shenderova A, Mallery SR, Schwendeman SP,. 2000. Stabilization of vinca alkaloids encapsulated in poly (lactide-co-glycolide) microspheres. Pharm Res 17: 677-683.
33. Mattos DMM, Gomes ML, Freitas RS, Bernardo-Filho M,. 2001. Model to evaluate the toxic effect of drugs: Vincristine effect in the mass of organs and in the distribution of radiopharmaceuticals in mice. Mut Res 496: 137-143.
34. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ,. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21: 1249.
35. McCune JS, Lindley C,. 1997. Appropriateness of maximum-dose guidelines for vincristine. Am J Health Syst Pharm 54: 1755.
36. Meeran SM, Katiyar S, Katiyar SK,. 2008. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229: 33-43.
37. Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, Wei D, Xiao H,. 2013. The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked Mice. Antioxid Redox Signal [Epub ahead of print].
38. Mollinedo F, Gajate C,. 2003. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450.
39. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N,. 2005. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 224: 53-65.
40. Owellen RJ, Hartke CA, Dickerson RM, Hains FO,. 1976. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class. Cancer Res 36: 1499.
41. Oyadomari S, Mori M,. 2003. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-3389.
42. Patil JB, Kim J, Jayaprakasha G,. 2010. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 645: 70-78.
43. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME,. 1994. 5-Fluorouracil related toxic myocarditis: Case reports and pathological confirmation. Can J Cardiol 10: 861.
44. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, Holy J,. 2008. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 61: 1007-1018.
45. Silverman JA, Reynolds L, Deitcher SR,. 2013. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia. J Clin Pharmacol 53: 1139-1145.
46. Singh J, Kakkar P,. 2009. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol 123: 22-26.
47. Skobel E, Kammermeier H,. 1997. Relation between enzyme release and irreversible cell injury of the heart under the influence of cytoskeleton modulating agents. Biochim Biophys Acta 1362: 128-134.
48. Smith EM, Li L, Hutchinson RJ, Ho R, Burnette WB, Wells E, Bridges C, Renbarger J,. 2013. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Cancer Nurs 36: E49-E60.
49. Song XR, Zheng Y, He G, Yang L, Luo YF, He ZY, Li SZ, Li JM, Yu S, Luo X, Hou SX, Wei YQ,. 2010. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. J Pharm Sci 99: 4874-4879.
50. Tan W, Li Y, Chen M, Wang Y,. 2011. Berberine hydrochloride: Anticancer activity and nanoparticulate delivery system. Int J Nanomedicine 6: 1773-1777.
51. Tange R, Vuzevski V,. 1984. Changes in the stria vascularis of the guinea pig due to cis-platinum. Eur Arch Otorhinolaryngol 239: 41-47.
52. Tyagi AK, Singh RP, Agarwal C, Chan DCF, Agarwal R,. 2002. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis. Clin Cancer Res 8: 3512-3519.
53. Upadhyay SN, Yadav RP,. 1999. Application of protoberberine alkaloid, berberine, an immunosuppressive agenteditor editors: Google Patents.
54. Venkatramani R, Malogolowkin M, Davidson TB, May W, Sposto R, Mascarenhas L,. 2013. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS ONE 8: e68416.
55. Woodahl EL, Crouthamel MH, Bui T, Shen DD, Ho RJ,. 2009. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol 64: 183-188.
56. Wu M, Wang J, Liu L,. 2010. Advance of studies on anti-atherosclerosis mechanism of berberine. Chin J Integr Med 16: 188-192.
57. Yang M, Wei D, Mo C, Zhang J, Wang X, Han X, Wang Z, Xiao H,. 2013. Saturated fatty acid palmitate-induced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes. Lipids Health Dis 12: 104.
58. Youn MJ, So HS, Cho HJ, Kim HJ, Kim Y, Lee JH, Sohn JS, Kim YK, Chung SY, Park R,. 2008. Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biol Pharm Bull 31: 789-795.
59. Yuen MF, Hou JL, Chutaputti A,. 2009. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 24: 346-353.
60. Zhang R, Dougherty D, Rosenblum M,. 1990. Laboratory studies of berberine used alone and in combination with 1, 3-bis (2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chin Med J 103: 658.
61. Zhao Q, Wang J, Zou MJ, Hu R, Zhao L, Qiang L, Rong JJ, You QD, Guo QL,. 2010. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism. Toxicol Lett 197: 201-210.
62. Zhou Y, Ling XL, Li SW, Li XQ, Yan B,. 2010. Establishment of a human hepatoma multidrug resistant cell line in vitro. World J Gastroenterol 16: 2291-2297.